Immunogenicity and Safety Study of Monovalent Omicron XBB.1.5 Vaccine as a Booster in Adults
Clinical trial NCT06567457 · WITHDRAWN
Trial details
- NCT number
- NCT06567457
- Sponsor
- Clover Biopharmaceuticals AUS Pty
- Status
- WITHDRAWN
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2023-10-01
- Primary completion
- 2024-09-01
- Enrollment
- 0
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.